Plain-English translation of NCT05743582 on ClinicalTrials.gov ↗ · Source last updated ·
Researchers are trying to understand why people with chronic obstructive pulmonary disease (COPD) have ongoing inflammation in their lungs that doesn't respond well to current treatments. This study collects blood samples and lung fluid from people with COPD, smokers without lung disease, and non-smokers to compare their immune systems and learn why some COPD patients get worse faster and have more infections.
Current COPD treatments don't stop the disease from getting worse, and doctors don't fully understand why some patients' immune systems fail to fight off bacteria effectively. This research could help scientists develop better treatments that actually address the root cause of lung inflammation rather than just managing symptoms.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be asked to donate a blood sample. Depending on which group you're in, you may also have a bronchoscopy—a procedure where a thin tube is gently passed into your lungs to collect fluid that helps researchers study your immune cells. The researchers will compare immune function between people with COPD and healthy volunteers to identify why some patients are more susceptible to infections and disease progression.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United Kingdom